NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Torrid Holdings Inc. ("Torrid Holdings Inc.") (NYSE:CURV) concerning possible violations of federal securities laws. On October 7, 2024, Torrid announced the termination of "Ms. Elizabeth Muñoz-Guzman, the [Company’s] Executive Vice President and Chief […]

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Nomura Holdings, Inc. ("Nomura Holdings, Inc.") (NYSE:NMR) concerning possible violations of federal securities laws. Media outlets reported on September 30, 2024, that Nomura was excluded as lead manager for several yen bond deals

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Elastic N.V. ("Elastic N.V.") (NYSE:ESTC) concerning possible violations of federal securities laws. Elastic announced on August 30, 2024, that it was reducing its revenue forecast for the year, a move that prompted a

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Biomea Fusion, Inc. ("Biomea Fusion, Inc.") (NASDAQ:BMEA) concerning possible violations of federal securities laws. Biomea issued a press release on June 6, 2024, announcing that it "has received notice from the U.S. Food

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Temenos AG ("Temenos AG") (OTC PINK:TMSNY) concerning possible violations of federal securities laws. On February 15, 2024, securities analyst Hindenburg Research published a research report titled Temenos: Major Accounting Irregularities, Failed Products and

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Proto Labs, Inc. ("Proto Labs") (NYSE:PRLB) concerning possible violations of federal securities laws. On November 4, 2022, Proto reported Q3 results meeting the low end of its prior guidance and then announced lower

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of MaxLinear, Inc. ("MaxLinear") (NASDAQ:MXL) concerning possible violations of federal securities laws. On July 24, 2024, after the market closed, MaxLinear announced earnings results for its second quarter of 2024 and that net revenue

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Endava plc (NYSE:DAVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/endava-lawsuit-submission-form?prid=108452&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Sage Therapeutics, Inc. (NASDAQ:SAGE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sage-therapeutics-lawsuit-submission-form?prid=108451&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESSWIRE / October 15, 2024 / If you suffered a loss on your Edwards Lifesciences Corporation (NYSE:EW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/edwards-lifesciences-lawsuit-submission-form?prid=108450&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call